@article{4a336d3f639843dead9d470cb93ae68d,
title = "Association of VHL genotype with pancreatic neuroendocrine tumor phenotype in patients with von hippel-lindau disease",
author = "Amit Tirosh and Sadowski, {Samira M.} and Linehan, {W. Marston} and Libutti, {Steven K.} and Dhaval Patel and Naris Nilubol and Electron Kebebew",
note = "Funding Information: PatientsdiagnosedwithVHLdiseaseunderwentgenetictest-ing for mutations in the 3 coding exons and exon-intron boundaries of the VHL gene and for partial or complete deletion or duplication of the VHL gene in Clinical Laboratory Improvement Amendments–approved laboratories.6 This study was approved by the institutional review board of the National Cancer Institute, and written informed consent was obtained from all patients enrolled in the study. All data were deidentified. Funding Information: Author Affiliations: Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Tirosh); Endocrine and Thoracic Surgery, University Hospitals of Geneva, Geneva, Switzerland (Sadowski); Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (Linehan); Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick (Libutti); RWJBarnabas Health, West Orange, New Jersey (Libutti); Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (Patel, Nilubol, Kebebew).",
year = "2018",
month = jan,
doi = "10.1001/jamaoncol.2017.3428",
language = "American English",
volume = "4",
pages = "124--126",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "1",
}